Symptoms and Physical Activity in COPD patients in Europe

Trial Identifier:	D5970R00006
Sponsor:	AstraZeneca
NCTID::	NCT03031769
Start Date:	December 2016
Primary Completion Date:	August 2017
Study Completion Date:	August 2017
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Romania	Iasi, Romania

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.